Soliris 300 mg concentrate for solution for infusion, Pozelimab, Cemdisiran, Ultomiris 300 mg/3 mL concentrate for solution for infusion
R3918-PNH-2021
Phase 3 small_molecule active
Quick answer
Soliris 300 mg concentrate for solution for infusion, Pozelimab, Cemdisiran, Ultomiris 300 mg/3 mL concentrate for solution for infusion for Paroxysmal nocturnal haemoglobinuria (PNH) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Paroxysmal nocturnal haemoglobinuria (PNH)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active